VERAVAS, Inc.

VERAVAS, Inc. is a biotechnology company based in Austin, Texas, founded in 2017. The company specializes in laboratory diagnostics using its proprietary VeraBIND™ technology, which enhances biomarker isolation and eliminates sample interferences for early disease detection. With a focus on processing complex patient samples such as blood, saliva, urine, and stool, VeraBIND enables the purification and concentration of low-abundance biomarkers, supporting accurate detection and rapid development of diagnostics.

The company offers products like the VeraBIND Tau Assay, designed to detect tau pathology in Alzheimer's disease at its earliest stages, and general solutions for sample preparation that enhance sensitivity for biomarkers in liquid biopsies. VERAVAS is led by experienced executives, including CEO John Forrest and Chief Scientific Officer Josh Soldo, and is supported by a Scientific Advisory Board with expertise in various medical fields. The company aims to improve patient outcomes by reducing misdiagnoses and serves healthcare providers, clinical labs, researchers, and diagnostic manufacturers.